Format

Send to

Choose Destination
J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:240-50. doi: 10.1016/j.vascn.2016.05.003. Epub 2016 May 13.

Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging.

Author information

1
Q-State Biosciences, Cambridge, MA, USA.
2
GlaxoSmithKline-Safety Assessment, King of Prussia, PA, USA. Electronic address: khuram.w.chaudhary@gsk.com.
3
GlaxoSmithKline-Safety Assessment, King of Prussia, PA, USA.
4
GlaxoSmithKline-Alternative Discovery and Development, Cambridge, MA, USA.
5
Department of Physics, Harvard University, Cambridge, MA, USA; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA.

Abstract

INTRODUCTION:

The Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative seeks an in vitro test to accurately predict clinical Torsades de Pointes (TdP). We developed a cardiotoxicity assay incorporating simultaneous measurement of the action potential (AP) waveform and Ca(2+) transient (CT) in human iPSC-derived cardiomyocytes (CMs). Concurrent optogenetic pacing provided a well-controlled electrophysiological background.

METHODS:

We used the Optopatch platform for all-optical electrophysiology (Hochbaum et al., 2014). In a monolayer culture, a subset of cells expressed a genetically encoded, calcium and voltage reporter, CaViar (Hou, Kralj, Douglass, Engert, & Cohen, 2014), while others expressed a channelrhodopsin variant, CheRiff. Optical pacing of CheRiff-expressing cells synchronized the syncytium. We screened 12 compounds (11 acute, 1 chronic) to identify electrophysiological (AP rise time, AP50, AP90, beat rate) and CT effects in spontaneously beating and paced cultures (1Hz, 2Hz).

RESULTS:

CaViar reported spontaneous and paced APs and CTs with high signal-to-noise ratio and low phototoxicity. Quinidine, flecainide, E-4031, digoxin and cisapride prolonged APs, while verapamil and nifedipine shortened APs. Early after depolarizations (EADs) were elicited by quinidine, flecainide and cisapride. All but four compounds (amiodarone, chromanol, nifedipine, verapamil) prolonged AP rise time. Nifedipine and verapamil decreased CT amplitude, while digoxin increased CT amplitude. Pentamidine prolonged APs after chronic exposure.

DISCUSSION:

The Optopatch platform provides a robust assay to measure APs and CTs in hiPSC-CMs. This addresses the CiPA mandate and will facilitate comparisons of cell-based assays to human clinical data.

KEYWORDS:

Cardiomyocytes; Cardiotoxicity; Channelrhodopsin; Comprehensive in vitro Proarrhythmia Assay; Human induced pluripotent stem cells; Methods; Optogenetics; Pacing; Torsades de Pointes; Voltage indicator

PMID:
27184445
DOI:
10.1016/j.vascn.2016.05.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center